Hologic Beats on Q4 Earnings, Revenues; FY16 View Strong

Hologic Inc.HOLX reported fourth quarter fiscal 2015 adjusted earnings per share (EPS) of 43 cents, up 13.2% year over year (excluding the one time benefit of amending the company's license agreement with Roka Bioscience). Adjusted EPS also beat the